Latest / Pharmacy Podcast Network / Rare & Resilient: Navigating Pediatric Rare Diseases with Rarus Med | Pediatric Pharmacist Review
Transcript
- 0:05Speaker 1: You are listening to the global network of podcasters dedicated
- 0:09Speaker 1: to the pharmacy profession.
- 0:10Speaker 2: Welcome to the Pharmacy Podcast Network.
- 0:29Speaker 3: Adverse drug reactions or ADRs, are a serious issue in
- 0:32Speaker 3: healthcare today. The pharmacist is the last line of defense
- 0:36Speaker 3: to help prevent ADRs. A rising role of the pharmacist
- 0:40Speaker 3: is the specialist who focuses on our children. Pediatric pharmacy
- 0:44Speaker 3: ensures safe and effective drug use and optimal medication therapy
- 0:48Speaker 3: outcomes and children up to eighteen years of age. Currently,
- 0:51Speaker 3: there are more than one four and fifty board certified
- 0:54Speaker 3: pediatric pharmacy specialists known as BPS. If you're interested in
- 0:59Speaker 3: this field of pharmacy, this podcast is for you. All right, everyone,
- 1:04Speaker 3: let's give it up for our host.
- 1:09Speaker 4: Hey, listeners, welcome back to the Pediatric Pharmacist Review. I
- 1:13Speaker 4: am one of your co hosts, Justin Cole, and I'm
- 1:16Speaker 4: excited to have Jenna Quenn back with me today. Jenna,
- 1:19Speaker 4: it's been a minute.
- 1:20Speaker 5: It has been.
- 1:22Speaker 6: We've been really ramping up over here at perfecting PEDS
- 1:28Speaker 6: with going from hundreds of patients like.
- 1:33Speaker 5: Five hundred to now five thousand.
- 1:35Speaker 6: So because of that, I've had my head down focusing on,
- 1:41Speaker 6: you know, scaling this band boy with our amazing, perfecting
- 1:45Speaker 6: pied staff. But Mary, my chiefest staff, is absolutely fabulous
- 1:50Speaker 6: because I can throw her in pretty much unprepared to
- 1:54Speaker 6: any situation and she just flies. And so we we're
- 1:58Speaker 6: tag teaming and consider us one. But Mary is seeing
- 2:02Speaker 6: a patient today, so I'm taking over again.
- 2:05Speaker 5: But it's thank you for letting us the flavor of
- 2:09Speaker 5: the day. Poor Justin. Well, it's probably better because I
- 2:12Speaker 5: love I'm obsessed with Mary. But you don't even know
- 2:15Speaker 5: who's going to show up. Justin's not sure who's going
- 2:18Speaker 5: to co host it. The it's kind of like a.
- 2:20Speaker 6: Surprise every day every time we host the show.
- 2:24Speaker 5: So thank you. I missed, I missed you, and I
- 2:28Speaker 5: do love I do love this and I'm excited for
- 2:31Speaker 5: our guests today.
- 2:32Speaker 4: Yeah, I'm excited to have you back on the podcast
- 2:35Speaker 4: as my partner in crime. But man, Mary, she is
- 2:39Speaker 4: She's a rock star. So Mary, if you're listening to this,
- 2:41Speaker 4: we miss you this week, looking forward to having you
- 2:43Speaker 4: back on the podcast soon. Well, let's go ahead and
- 2:45Speaker 4: transition to our guests today. So I'm really excited to
- 2:49Speaker 4: be talking with a couple of people from rarest Med.
- 2:53Speaker 4: So Isabelle Vache is here with us as the founder
- 2:58Speaker 4: of rarest Med, and we also Dana Tate here who
- 3:01Speaker 4: has some public health focus experience and unique personal story.
- 3:05Speaker 4: I think that really flows into why she's so passionate
- 3:08Speaker 4: about the work that's being done at rares Med. So Isabelle,
- 3:12Speaker 4: thank you so much for joining us. Dana, we thank
- 3:15Speaker 4: you as well. And I'm just going to kick it
- 3:17Speaker 4: off by letting the two of you tell us a
- 3:19Speaker 4: bit about what you do at rarest Med and maybe
- 3:23Speaker 4: the story behind it. So Isabelle, do you mind maybe
- 3:26Speaker 4: kicking us off?
- 3:27Speaker 2: Yeah, absolutely, thank you so much. We are so excited
- 3:31Speaker 2: to be here and just love and adore perfecting peds
- 3:36Speaker 2: and love Mary and Jenna and are just thrilled to
- 3:41Speaker 2: participate today. I'm going to tell you a little bit.
- 3:45Speaker 2: Maybe we could start with what inspired the creation of
- 3:48Speaker 2: rarest Med. And it's an important story because it's deeply personal.
- 3:55Speaker 2: My journey with rare disease began when my oldest daughter
- 3:59Speaker 2: suffered to catastrophic stroke in twenty nineteen. It was an
- 4:04Speaker 2: event that could have been prevented had a rare genetic
- 4:07Speaker 2: mutation been identified, and when she experienced an earlier, more
- 4:13Speaker 2: minor stroke a decade prior.
- 4:17Speaker 7: Then, in twenty.
- 4:18Speaker 2: Twenty three, my youngest daughter was diagnosed with the asinophilic esophagitis,
- 4:23Speaker 2: which is another rare disease, after a lifetime of dismissed symptoms,
- 4:28Speaker 2: and I found myself at a crossroads. Despite having ten
- 4:33Speaker 2: years of nursing experience in more than thirty years in
- 4:35Speaker 2: medical impatient education, I found myself lost and alone and
- 4:41Speaker 2: terrified and surprised that I was in such a place
- 4:47Speaker 2: with all that kind of a background. You know, I
- 4:50Speaker 2: think as healthcare providers, we always know that no family
- 4:55Speaker 2: should have to navigate these kinds of challenges alone, whether
- 4:58Speaker 2: it's rare.
- 4:58Speaker 7: Disease or not. We know that, but you know, the
- 5:05Speaker 7: lived experience.
- 5:06Speaker 2: Through that lived experience, I came to understand the full
- 5:09Speaker 2: depth of that truth in a way that surprised me.
- 5:13Speaker 2: You know, the isolation, the fear, the helplessness that came
- 5:18Speaker 2: when the right knowledge and support aren't there, and I
- 5:22Speaker 2: know how to get support, you know, with my background.
- 5:24Speaker 7: And I couldn't find it.
- 5:27Speaker 2: I know now more than ever that education, when it's
- 5:29Speaker 2: designed with purpose and compassion, that's the power to transform lives.
- 5:35Speaker 2: Improve patient outcomes and even prevent tragedies like the ones
- 5:41Speaker 2: my family endured and many others. And it was through
- 5:44Speaker 2: these experiences that rares Med began to take shape and
- 5:49Speaker 2: I officially launched the company.
- 5:52Speaker 7: I can't even believe it.
- 5:53Speaker 2: It was just a year ago on Rare Disease Day
- 5:56Speaker 2: twenty twenty four. So yeah, yeah, you know, I took
- 6:01Speaker 2: a leap of faith and jumped our educational We call
- 6:05Speaker 2: it an educational ecosystem, and it embodies my unique perspective
- 6:10Speaker 2: as a nurse and an educator, but most importantly a
- 6:14Speaker 2: mother who's navigated the complexities of rare diseas's firsthand. This
- 6:20Speaker 2: lived experience really fuels my personal commitment to transforming rare
- 6:24Speaker 2: disease education by ensuring that healthcare providers, patients, and families
- 6:30Speaker 2: have access to the knowledge, resources and support that we're
- 6:33Speaker 2: missing in our journey.
- 6:35Speaker 7: And I would love to.
- 6:37Speaker 2: Turn it over to Dana here about to talk a
- 6:40Speaker 2: little bit about what the unique needs are in the
- 6:42Speaker 2: rare disease community that we're aiming to address.
- 6:45Speaker 7: So Dana, would you mind taking that.
- 6:48Speaker 8: Yeah, absolutely, So. Rarest Med is kind of.
- 6:52Speaker 9: Built as a holistic educational ecosystem, kind of is the
- 6:56Speaker 9: belt touched on that a little bit. So we have
- 6:58Speaker 9: rarest C which provides cutting edge, interactive continuing education for clinicians,
- 7:06Speaker 9: and then we have rarest Galaxy, which is a dynamic
- 7:10Speaker 9: platform designed for patients and families. Anyone with rare disease
- 7:18Speaker 9: kind of knows that rare diseased education has long suffered
- 7:24Speaker 9: from a kind of one size fits.
- 7:26Speaker 8: All approach and it kind of fails to address.
- 7:30Speaker 9: Any diverse learning needs and there's a lot of systemic
- 7:35Speaker 9: barriers and accessibility gaps.
- 7:39Speaker 8: So Rare SMD was created to change that.
- 7:43Speaker 9: We bridge the gap, or we're trying to bridge the
- 7:47Speaker 9: gap between clinicians who need specialized evidence based knowledge and
- 7:53Speaker 9: then the patients and families that are seeking understandable, actionable education.
- 8:00Speaker 9: So what RARES does is we ensure that learning is
- 8:03Speaker 9: not just informative, but transformative. So through our innovative multi
- 8:08Speaker 9: channel education, we are trying to empower every stakeholder in
- 8:14Speaker 9: the rare disease space.
- 8:15Speaker 8: So we're trying to.
- 8:17Speaker 9: Meet them where they are and equipping them with that
- 8:20Speaker 9: knowledge they need to navigate such complex conditions with confidence.
- 8:28Speaker 6: That's amazing, Thank you, And I will share which I
- 8:33Speaker 6: often don't talk about.
- 8:36Speaker 5: Because I don't.
- 8:36Speaker 6: Again, it's confusing when you can when one of your
- 8:39Speaker 6: loved ones get these diagnosis and.
- 8:41Speaker 5: I don't even like again, you don't even know what
- 8:44Speaker 5: to make of it.
- 8:44Speaker 6: So my now eight year old last year started randomly
- 8:51Speaker 6: shaking just her her one hand and I honestly look
- 8:57Speaker 6: like Parkinson's And so they call me from school. The
- 9:00Speaker 6: first time, I thought, okay, this is weird. Her hands
- 9:03Speaker 6: just tired, but it wouldn't stop. So then I was like,
- 9:07Speaker 6: oh my god, what if this is a seizure. What
- 9:09Speaker 6: if this is a neurologic disorder? So I took her
- 9:12Speaker 6: to the er to get you know, the million dollar
- 9:16Speaker 6: work up for us to walk away with no answer.
- 9:20Speaker 6: So they knew it wasn't a stroke. They did an
- 9:23Speaker 6: EEG to rule out seizures, many many MRIs for us
- 9:28Speaker 6: to get the diagnosis of benign essential tremor. Then, of course,
- 9:34Speaker 6: just like justin I've focused in neurology, and I was like,
- 9:38Speaker 6: I've never seen a kid with a benign essential tremor
- 9:42Speaker 6: and what are you supposed to do it that if
- 9:43Speaker 6: you google it and look it up for adults, like
- 9:47Speaker 6: one of the diagnosis or one of the treatments, which
- 9:50Speaker 6: is I teased her, is you drink you drink alcohol
- 9:54Speaker 6: and see if it breaks. So I was teasing my
- 9:56Speaker 6: eight year old, like you want a glass.
- 9:57Speaker 5: Of wine, and we're like, okay, well that's gonna work.
- 10:01Speaker 5: So that's out.
- 10:03Speaker 6: And then you start looking at the other meds that
- 10:05Speaker 6: they have available for benign essential tremors in the adult population,
- 10:10Speaker 6: and they don't even trance like the thought of putting
- 10:13Speaker 6: my kin on blood pressure meds when her blood pressure
- 10:17Speaker 6: is already low and it could cause exercise fatigue and
- 10:21Speaker 6: she's huge in her activities, or it was other anti epileptics.
- 10:26Speaker 6: So as a lost mom, I reviewed her labs and
- 10:30Speaker 6: realized that her magnesium was slightly low and that that
- 10:34Speaker 6: can cause like some sort of tremors.
- 10:37Speaker 5: I started supplementing magnesium. It went away. The neurologists told
- 10:40Speaker 5: me I was crazy.
- 10:41Speaker 6: I took the magnesium off, the tremors came back, put
- 10:45Speaker 6: the magnesium back on, they went away. I and again,
- 10:49Speaker 6: I'm a pharmacist and a pediatric pharmacist and a neurology pharmacist,
- 10:53Speaker 6: And because this is so rare, I don't even know
- 10:56Speaker 6: what to do with that experience. With that knowledge with like, again,
- 11:01Speaker 6: she's n of very small in the US, and actually
- 11:04Speaker 6: that's I don't actually really talk about it because I
- 11:06Speaker 6: don't even know what to make of it. But so
- 11:10Speaker 6: thank you for what you guys are doing, because you
- 11:13Speaker 6: know there's caregivers and even as a provider and a pharmacist,
- 11:17Speaker 6: I'm like, I don't know that was that a fluke
- 11:19Speaker 6: was that helpful? And so what you guys are doing
- 11:22Speaker 6: is truly amazing and I absolutely love that.
- 11:28Speaker 5: So can you can you guys tell.
- 11:31Speaker 6: Us how this differs then your traditional CE medical education
- 11:38Speaker 6: both from a provider's and a caregivers perspective.
- 11:42Speaker 2: Oh, I would love to answer that question, Jenna.
- 11:47Speaker 7: And this is.
- 11:47Speaker 2: Really kind of bringing the full weight of all of
- 11:51Speaker 2: the knowledge that I've accumulated over thirty years working in
- 11:56Speaker 2: the CME space, in the patient education space, and you know,
- 12:01Speaker 2: trying to always stay ahead of the curve with what's
- 12:04Speaker 2: happening in education, and you know, I it's getting better,
- 12:10Speaker 2: but traditional medical education is can be extremely boring. You know,
- 12:16Speaker 2: it's often lecture based, passive design for common conditions, but
- 12:23Speaker 2: you know, rare diseases, And I would argue really all
- 12:26Speaker 2: of medical education but especially for rare diseases, requires a
- 12:30Speaker 2: fundamentally different approach. It demands to critical thinking or really
- 12:35Speaker 2: suspicion multidisciplinary perspectives. So at RARESMAD, we've tried to flip
- 12:45Speaker 2: the traditional model by using what we again consider an
- 12:50Speaker 2: educational ecosystem. It's evolving, but our foundation approach is we
- 12:57Speaker 2: marry virtual clinics that put HCPs into real world diagnostic
- 13:02Speaker 2: and treatment scenarios with many documentaries that integrate patient voices
- 13:09Speaker 2: directly into learning, as well as gamified learning for patients
- 13:14Speaker 2: and families. These three pieces always exists together. We never
- 13:21Speaker 2: do them in silos, so you will never find a
- 13:24Speaker 2: virtual clinic without that tie into the patient and vice versa.
- 13:30Speaker 10: And not only that, we take the patient.
- 13:34Speaker 2: Who has whichever rare disease we are focusing on, and
- 13:38Speaker 2: they are integrated into the virtual clinics as well.
- 13:41Speaker 7: For the HCP education.
- 13:44Speaker 2: So there is this back and forth between a faculty
- 13:47Speaker 2: that includes healthcare provider experts and a patient or patients
- 13:51Speaker 2: with a disease. We just finished a program in an
- 13:54Speaker 2: indiopathic hypersomnia and our patient voices amazing. We're working on
- 13:59Speaker 2: hereditary in you a dema right now and amazing faculty
- 14:03Speaker 2: and a mother and a daughter are part of the
- 14:06Speaker 2: faculty who both have HAE.
- 14:08Speaker 7: So we really have this again.
- 14:12Speaker 2: Looking at looking at it from a holistic rather than
- 14:15Speaker 2: a siloed perspective.
- 14:17Speaker 7: One of the things we're working on.
- 14:19Speaker 2: I think that's very different, but it is an important
- 14:22Speaker 2: part of our plan is adaptive intelligence driven learning that
- 14:26Speaker 2: personalizes education in real time. You know, we taught I
- 14:31Speaker 2: don't think you can turn a page without seeing AI, right,
- 14:35Speaker 2: But we're really exploring what we call emergence intelligence, which
- 14:40Speaker 2: is a more dynamic and evolving model designed specifically for
- 14:43Speaker 2: rare disease education. The goal is to create a system
- 14:47Speaker 2: that not only personalizes learning in real time, but also
- 14:50Speaker 2: adapts based on new discoveries and patient insights and clinical engagement.
- 14:56Speaker 2: So you know, our philosophy is it's not just about
- 15:00Speaker 2: memorizing guidelines. It's about changing how providers diagnose, treat, and
- 15:04Speaker 2: engage with rare disease patients and by SUBVERSTA. So that's
- 15:11Speaker 2: where we are with our rarest med focus.
- 15:16Speaker 4: Yeah, that's fantastic. Being an educator, I'm soaking so much
- 15:20Speaker 4: of this up. There's a lot that we need to
- 15:22Speaker 4: learn about taking our current approach to education and adapting
- 15:27Speaker 4: that really to our learner in a way that fosters
- 15:32Speaker 4: change and not just knowledge transactional type of approaches to learning. Right,
- 15:36Speaker 4: So what you're doing is amazing. I'd love to step
- 15:40Speaker 4: back just a little bit for our listeners. For us,
- 15:43Speaker 4: Jenna and I am.
- 15:44Speaker 1: Repeats, we're used to rare disease.
- 15:46Speaker 4: Kiddos all the time, but maybe we could define for
- 15:50Speaker 4: our listeners who maybe aren't as familiar.
- 15:52Speaker 1: What qualifies as a rare disease.
- 15:56Speaker 4: And can you give us some examples of those that
- 15:59Speaker 4: you have created some educational tools for.
- 16:03Speaker 1: Yes.
- 16:03Speaker 2: Absolutely, So it's interesting. I like this question because even
- 16:13Speaker 2: when we started Rare SMAD, EOE was considered a rare disease.
- 16:21Speaker 2: The latest is that because there's more attention and understanding
- 16:29Speaker 2: around EOE, it's kind of moved out of the ranks
- 16:33Speaker 2: of rare disease.
- 16:35Speaker 10: So, you know, is a disease really rare or have
- 16:40Speaker 10: we just not.
- 16:41Speaker 7: Had enough optics on it?
- 16:44Speaker 2: You know, I mean there are you know, definitions of
- 16:50Speaker 2: what a rare disease is, but again that can change
- 16:53Speaker 2: with you know, with just more understanding and education. You know,
- 16:57Speaker 2: with EOE, we didn't have any treatments. We still have
- 17:01Speaker 2: no treatments for what is going on with my daughter.
- 17:04Speaker 2: But we then, you know, we do pixe it. It
- 17:09Speaker 2: came onto the scene and finally gave patients a treatment
- 17:15Speaker 2: option and more people started learning about it. And now
- 17:18Speaker 2: it's not it's it's slowly moving off the we're identifying work.
- 17:22Speaker 10: You know, a lot more EO E than we ever
- 17:25Speaker 10: when we ever thought was there.
- 17:27Speaker 7: So, you know, I think we have to keep that
- 17:30Speaker 7: in mind and we so we focus on because we
- 17:38Speaker 7: only launched a year ago.
- 17:40Speaker 2: We have our two major programs that are under our
- 17:43Speaker 2: belt with more to come. As I mentioned, one is
- 17:47Speaker 2: idiopathic hypersomnia and the other is hereditary angioedema. From a
- 17:56Speaker 2: from a focused perspective, I constant on all the rare
- 18:02Speaker 2: diseases and disorders that are currently categorized as rare, and
- 18:06Speaker 2: there are hundreds of them. But I just think the
- 18:11Speaker 2: question is so important because we have to keep in
- 18:13Speaker 2: mind is it really as rare as we think it is?
- 18:18Speaker 5: Right?
- 18:19Speaker 7: Yeah, I mean even.
- 18:21Speaker 6: I'm thinking back personally to when like back in the
- 18:26Speaker 6: day quote unquote, I have celiacs, right, and so nobody
- 18:29Speaker 6: talked about that, and my mom was like, I didn't.
- 18:31Speaker 5: Even think to test you.
- 18:32Speaker 6: I just thought you're, you know, four eleven, barely five
- 18:36Speaker 6: foot and that's just like you know, you were negative
- 18:39Speaker 6: five percentile and that was how your things were supposed
- 18:42Speaker 6: to be.
- 18:42Speaker 5: And so I'm like, Mom, I understand how you miss this.
- 18:46Speaker 6: She's just like, nobody ever talked about it so and
- 18:49Speaker 6: it wasn't so I can totally see how You're right.
- 18:54Speaker 6: It changes over time. What are some of your biggest challenges?
- 19:00Speaker 5: Is in the rare disease education and advocacy space.
- 19:05Speaker 7: I love you to grab that one.
- 19:08Speaker 5: This is her soapbox.
- 19:10Speaker 10: Everybody, get ready, We're ready.
- 19:13Speaker 9: So one of the biggest barriers is diagnostic delay. I
- 19:20Speaker 9: have so much personal experience with that, but I won't
- 19:24Speaker 9: go We'd be here for the next four hours. But
- 19:28Speaker 9: many rare diseases take years to identify because providers lack
- 19:34Speaker 9: exposure to them.
- 19:35Speaker 8: Kind of piggybacking off of what Isabelle was kind of
- 19:38Speaker 8: just saying.
- 19:40Speaker 9: Another major issue is fragmented information, so patients are struggling
- 19:46Speaker 9: to find trustworthy resources, and then clinicians often lack access
- 19:52Speaker 9: to the latest treatment advances, so.
- 19:57Speaker 1: Rarest galaxy.
- 19:58Speaker 5: What we're doing.
- 19:59Speaker 8: We're trying to solve.
- 20:00Speaker 9: That by connecting patients, families, and hcaps through shared learning
- 20:06Speaker 9: experiences and integrating patient storytelling into medical education so that
- 20:13Speaker 9: provide so that providers learn the human impact alongside the
- 20:19Speaker 9: science and then yeah, and then off offering tailored learning paths,
- 20:25Speaker 9: so whether you're a newly diagnosed patient, a caregiver, or
- 20:29Speaker 9: a specialist, you can get that information and that it's
- 20:34Speaker 9: clear and relevant and actionable. So one of the most
- 20:39Speaker 9: important aspects to me is that patients aren't just included
- 20:44Speaker 9: their faculty in our programs. We elevate patient voices as educators,
- 20:52Speaker 9: not just in case studies, so that we can ensure
- 20:55Speaker 9: that medical education is built alongside.
- 20:59Speaker 8: The people that impacts the most.
- 21:03Speaker 2: Absolutely, you know, and I would I would say another
- 21:07Speaker 2: you know, I think there's a lot of challenges and
- 21:09Speaker 2: we probably would need a whole podcast on.
- 21:10Speaker 5: It, but.
- 21:14Speaker 2: Beyond the misdiagnosis is another major challenge is continued support
- 21:22Speaker 2: beyond the diagnosis. So you know, so many families fight
- 21:26Speaker 2: for years to get that rare disease diagnosis and then.
- 21:30Speaker 7: They get it and they are still lost.
- 21:34Speaker 2: A lot of times you know, clear treatment pathways or
- 21:38Speaker 2: long term management strategies. You know, education doesn't just stop
- 21:43Speaker 2: a diagnosis. It really has to evolve with the patient's journey.
- 21:47Speaker 2: And I you know, I think we have to sustaining
- 21:51Speaker 2: education through treatment, clinical trials, and emerging therapies because rare
- 21:56Speaker 2: disease is diagnosis is just the beginning, bridging the gap
- 22:02Speaker 2: between advocacy and action, ensuring that research, funding and policy
- 22:09Speaker 2: changes translate into real world solutions for patients and families,
- 22:14Speaker 2: and providing clarity on medication access, safety and management. Jenna,
- 22:21Speaker 2: I'm sure that one really resonates with you, especially for
- 22:24Speaker 2: pediatric patients we're dosing guidelines are often clear, unclear, or nonexistent.
- 22:30Speaker 2: So I think that's why, you know, platforms like rarest
- 22:36Speaker 2: Galaxy and others.
- 22:37Speaker 7: You know, we don't want to own this space. We're
- 22:40Speaker 7: not competitors.
- 22:41Speaker 2: We want everybody to kind of move and evolve together.
- 22:45Speaker 7: You know, I think we all have to. It's not
- 22:48Speaker 7: just education that.
- 22:49Speaker 2: We're doing, more empowering families with ongoing, evolving support. That's
- 22:55Speaker 2: such a huge piece of perfecting feeds. And they don't
- 23:00Speaker 2: just inform providers, they equip them to act confidently and
- 23:04Speaker 2: compassionately in a space where hesitation could mean the difference
- 23:08Speaker 2: between life and death.
- 23:12Speaker 4: You know, it's about one thing that strikes me as
- 23:14Speaker 4: you're talking about this is that busy clinicians often don't
- 23:18Speaker 4: have the time, even if they have all the resources,
- 23:20Speaker 4: to provide great patient education because rare diseases impact more
- 23:26Speaker 4: than just the medical side of things. But you guys
- 23:28Speaker 4: are looking at this holistically. You're looking at not only
- 23:32Speaker 4: the journey to diagnosis, but what do they need to
- 23:34Speaker 4: do to treat and manage the condition and the symptoms
- 23:38Speaker 4: that go along with it. Are their daily life challenges
- 23:41Speaker 4: and things in diet that need to change. What about
- 23:44Speaker 4: the emotional health aspects? You're getting all of that, and
- 23:48Speaker 4: so I just want to reiterate the point that this
- 23:51Speaker 4: I love that you say. This isn't a competition, right,
- 23:53Speaker 4: this is an opportunity for collaboration. And even looking at
- 23:58Speaker 4: what Jenna and her team at Perfecting PEDS are doing,
- 24:00Speaker 4: they spend a lot of time with these families, they
- 24:02Speaker 4: still don't have all the time they need to fully
- 24:05Speaker 4: educate these families that are struggling with managing a.
- 24:10Speaker 1: Child with a rare disease.
- 24:11Speaker 4: And so the more we can partner and create that ecosystem.
- 24:15Speaker 4: As you said, the better off we're going to be.
- 24:17Speaker 4: So I love that you guys are taking that approach.
- 24:20Speaker 4: Maybe if we could talk about one of those aspects
- 24:22Speaker 4: of holistic care a little bit, I'd love to just
- 24:25Speaker 4: hear about how you approach this in your education. So
- 24:27Speaker 4: let's talk about some of the daily life challenges like
- 24:30Speaker 4: diet and nutrition. What are some of the ways that
- 24:33Speaker 4: you go about providing high quality education to families who
- 24:38Speaker 4: maybe have to make some of those lifestyle changes to
- 24:42Speaker 4: help support their family.
- 24:44Speaker 7: Oh, I love that.
- 24:44Speaker 2: Question, Justin, and you know, I want to say thank
- 24:49Speaker 2: you for just I think the root of so many
- 24:54Speaker 2: problems are the working in silo's mentality and then the
- 24:59Speaker 2: US versus them mentality, and we absolutely do not want
- 25:05Speaker 2: to do that at BIRSMAD. You know, hence this collaboration,
- 25:09Speaker 2: even with perfecting PEDS in so many ways, because you know,
- 25:14Speaker 2: I can reach out to the communities that I've built
- 25:17Speaker 2: over the past thirty years, but I think it's important
- 25:20Speaker 2: to reach out beyond too, So I just wanted to
- 25:24Speaker 2: say thank you for saying that again. So you asked
- 25:31Speaker 2: about how do we approach that from a wider perspective,
- 25:36Speaker 2: a more holistic perspective, and so justin we tried to.
- 25:41Speaker 10: Do that in our patient on the patient.
- 25:45Speaker 2: Side, with our many documentaries and our games, you will
- 25:50Speaker 2: see very a very broad holistic treatment of topics where
- 25:58Speaker 2: we talk about diet and we talk about exercise. From
- 26:02Speaker 2: our patient's perspective, you know, what did you do, what
- 26:06Speaker 2: were your challenges, what kind of adjustments did you make?
- 26:09Speaker 7: You know, how did this work for you?
- 26:11Speaker 2: Dana could talk forever on this with the adjustments that
- 26:14Speaker 2: you know that she's had to make in her life,
- 26:16Speaker 2: but we UH were very careful to address that more
- 26:20Speaker 2: holistic overview, not just talk about treatments, pharmacological treatments, but.
- 26:28Speaker 7: Much broader take.
- 26:29Speaker 2: And when we also try to end particular mini documentaries
- 26:35Speaker 2: with words of hope, you know, because.
- 26:39Speaker 7: Sometimes there are no ultimate answers.
- 26:42Speaker 2: It's just the recognition that hey, I'm not alone, and
- 26:46Speaker 2: that can mean everything. So we we we do that
- 26:52Speaker 2: in our patient education in both the many documentaries and
- 26:55Speaker 2: the educational game, which is really fun by the way,
- 26:57Speaker 2: you got to you gotta try our climbing Big Foot
- 27:00Speaker 2: Mountain for h But on the on the HCP side,
- 27:08Speaker 2: the rarest ceast side where we're doing the virtual clinics.
- 27:12Speaker 2: We also broadened those discussions to incorporate pieces like that.
- 27:18Speaker 2: That's why we have, for example, our HAE program. One
- 27:24Speaker 2: of our faculty members is married. She is providing the
- 27:30Speaker 2: pharmacist voice in this interdisciplinary discussion on HAE. So it's
- 27:36Speaker 2: bringing again, you know, it's thinking outside the silos, outside
- 27:39Speaker 2: the boxes, and you know, we're all going to be
- 27:44Speaker 2: patients or we all have been patients. I'm sure probably
- 27:47Speaker 2: everybody on this call has been a patient. We got
- 27:49Speaker 2: to think back, like, we're patients, not just clinicians.
- 27:53Speaker 6: Yeah, I agree, because it's humbling when you're the patient,
- 27:57Speaker 6: and even more humbling for me when i'm you know,
- 28:02Speaker 6: I'm very quick to spew out to parents with little
- 28:05Speaker 6: anxiety what meds we should do, what meds we should give,
- 28:08Speaker 6: and what we should do, and then when it's my
- 28:10Speaker 6: own kids, I'm freaking out. So it's I'm like, what's
- 28:14Speaker 6: the voice of Benadrul or tyl like you just like
- 28:17Speaker 6: completely you can even it's just such a different experience
- 28:22Speaker 6: when you're on the other side of the of the table.
- 28:25Speaker 5: That's that's for sure.
- 28:28Speaker 6: In your experience, this is going to be a little
- 28:32Speaker 6: bit selfish of a question, but how can healthcare providers,
- 28:37Speaker 6: especially US pharmacists.
- 28:39Speaker 5: Improve the way they engage with families of children with
- 28:43Speaker 5: rare diseases? What what clinical grows do you have? Our
- 28:47Speaker 5: primary listeners are pharmacists.
- 28:50Speaker 10: Oh yes, my dear pharmacists.
- 28:53Speaker 2: You are so incredibly important and more than what most
- 28:57Speaker 2: people understand. Number one, and I think we have to
- 29:03Speaker 2: get that out, you know, that word out. Pharmacists are
- 29:06Speaker 2: not just dispensing medication, you know. So there's a lot
- 29:09Speaker 2: of education that we can do there about the more holistic,
- 29:13Speaker 2: wider role of the pharmacist. But you know, just to
- 29:18Speaker 2: to take it to specifically, the pharmacists in rare disease.
- 29:21Speaker 2: Farmists play a critical role in rare disease care, you know,
- 29:26Speaker 2: often more than most people realize. As I mentioned, but
- 29:30Speaker 2: in many cases they're the last line of defense between
- 29:33Speaker 2: a patient and an avoidable medication error.
- 29:36Speaker 7: You know, yet, rare.
- 29:38Speaker 2: Disease often prevents unique challenges that require a different approach
- 29:42Speaker 2: to engagement.
- 29:43Speaker 10: So here's my take on you know, how pharmacists make
- 29:48Speaker 10: a difference.
- 29:50Speaker 2: Recognize that rare disease medications aren't always straightforward. Many rare
- 29:55Speaker 2: disease treatments involve off label use, compounded medications or in
- 30:00Speaker 2: zygne therapy, specialized dosing.
- 30:04Speaker 10: The pharmacists be proactive and.
- 30:06Speaker 2: Learning about these treatments or rather than assuming that standard
- 30:10Speaker 2: protocols apply, and my pharmacists on the call jump in
- 30:13Speaker 2: and correct me if you disagree, because I am not
- 30:16Speaker 2: a pharmacist being an active partner in medication management, I
- 30:22Speaker 2: should probably just turn that over to Jenna.
- 30:23Speaker 7: But you know, families.
- 30:25Speaker 2: Often feel isolated when it comes to treatment decisions, and
- 30:29Speaker 2: pharmacists can bridge this gap by offering education on administration,
- 30:34Speaker 2: potential interactions, alternative formulations, you know, being the core of
- 30:41Speaker 2: shared decision making, especially for pediatric patients that you know
- 30:46Speaker 2: they need liquid suspensions or weight based dosing adjustments or
- 30:51Speaker 2: specialty pharmacy coordination. You know that is a I mean,
- 30:56Speaker 2: it's incredibly a critical role empowering families with clear compassion
- 31:03Speaker 2: and guidance.
- 31:04Speaker 10: You know, many rare disease parents feel dismissed.
- 31:08Speaker 2: Even if you feel like, oh wow, I know everything,
- 31:11Speaker 2: you know, I know it all, trust me, we don't.
- 31:15Speaker 2: Many rare disease parents can feel dismissed when they ask
- 31:20Speaker 2: questions or concerns.
- 31:22Speaker 7: You know. You know, pharmacists can change that.
- 31:24Speaker 2: They can validate their experiences, they can ensure that instructions
- 31:29Speaker 2: are clear and accessible. They can take the time to
- 31:32Speaker 2: check for potential roadblocks things like insurance issues, prior authorization requirements,
- 31:38Speaker 2: specialty pharmacy delays that can completely sideline a patient and
- 31:43Speaker 2: impact outcomes. So, you know, I think this kind of
- 31:48Speaker 2: is a full circle into into why I have been
- 31:51Speaker 2: so engaged and interested and excited for what Perfecting PEDS
- 31:55Speaker 2: is doing, because you know, perfecting PEDS kind of service
- 32:00Speaker 2: as that model. Sorry, Jen, I we didn't Jenna didn't
- 32:03Speaker 2: talk and I didn't talk about this beforehand.
- 32:06Speaker 7: I really honestly, we did it.
- 32:08Speaker 5: I promised we did it. Do you know?
- 32:09Speaker 7: I mean protecting peage.
- 32:11Speaker 2: They're the champions for pediatric medication management, and that's a
- 32:16Speaker 2: rare disease and outside rare disease, you know, for complex patients,
- 32:20Speaker 2: we need more purtacy professionals to understand how critical their
- 32:24Speaker 2: role is in supporting families the.
- 32:27Speaker 10: Right medication, the right form at the right time.
- 32:30Speaker 7: That can mean everything.
- 32:32Speaker 5: Yeah, I'll give you an example.
- 32:33Speaker 6: I was trying to look to see how common this is,
- 32:36Speaker 6: but I had a real life example this week.
- 32:38Speaker 5: One of my patients had, I I'm Mike Butcher. How
- 32:43Speaker 5: this is actually stated?
- 32:45Speaker 6: But it's Smith Lenley appetite syndrome. Okay, you know, how
- 32:51Speaker 6: do you say it?
- 32:53Speaker 7: I do not know. I have never just that you've
- 32:57Speaker 7: heard of.
- 32:57Speaker 1: It before I have.
- 32:59Speaker 4: Yeah, I believe it's Smith f Lemley op it. So
- 33:02Speaker 4: if I understand correctly yet yeah, yeah.
- 33:05Speaker 6: And so I'm like, but it's always humbling, And actually
- 33:10Speaker 6: I find that there's the most room for a pharmacists
- 33:15Speaker 6: in these types of situations, or or we can we
- 33:18Speaker 6: always have to stay curious, right, because I'm like, one,
- 33:21Speaker 6: I've never heard of this disease. So the first thing
- 33:23Speaker 6: I do, and I would love your critique on this
- 33:25Speaker 6: is usually I try to find they usually have national
- 33:28Speaker 6: organizations for that disease that house the most important knowledge,
- 33:32Speaker 6: so like there's usually a foundation where they collectively are
- 33:37Speaker 6: doing different research or or at least putting the most
- 33:41Speaker 6: innovative tips and tricks in. So the one thing when
- 33:44Speaker 6: I was reading about it, it can cause your cholesterol
- 33:49Speaker 6: to be low. But then a persecutor of it, I
- 33:54Speaker 6: don't want to completely butcher it. And it's only one
- 33:57Speaker 6: in twenty thousand people in the world have it, but
- 34:00Speaker 6: it's your your d hydroxy cholesterol is super elevated and
- 34:07Speaker 6: so but one of the they almost present like the
- 34:10Speaker 6: autistic population or an autism. That's again I feel like
- 34:14Speaker 6: that shouldn't be a rare disease, but by golly, it is.
- 34:17Speaker 5: We don't know enough about it.
- 34:18Speaker 6: But like they started him on any antipsychotic, and I'm
- 34:23Speaker 6: reading and I'm like, you can't use an antipsychotic in
- 34:26Speaker 6: this disease because it's actually going to make the seven
- 34:31Speaker 6: dehydroxylcholesterol higher and can put them at risk of cardiovascular issues.
- 34:37Speaker 5: And so I feel like, again, you're not going to
- 34:40Speaker 5: know it all.
- 34:40Speaker 6: But I think trying to find those like foundations or
- 34:44Speaker 6: those those people, even if it's like one and I've
- 34:48Speaker 6: seen one in twenty five diseases or one in fifty
- 34:51Speaker 6: like the foundation, and try to educate yourself on the
- 34:55Speaker 6: origin of the disease as well as anyone you can
- 35:00Speaker 6: give you clinical pearls that came before you, because that
- 35:03Speaker 6: was just a real live example, where like our healthcare
- 35:08Speaker 6: providers can be so instrumental if we stay curious in.
- 35:13Speaker 5: All the disease states, that are where.
- 35:15Speaker 6: So I just wanted to provide one real life example
- 35:18Speaker 6: and next time I know how to pronounce it. Justin
- 35:20Speaker 6: that was when the mom told me, and I'm honest
- 35:23Speaker 6: with parents. The grandmom told me. I was, I don't
- 35:25Speaker 6: know what that is. I'm going to have to read
- 35:27Speaker 6: about this. She's like, okay, And then I came back
- 35:29Speaker 6: the next time, I was like, we have to get
- 35:31Speaker 6: them off the.
- 35:31Speaker 5: Andis psychotic and on something else.
- 35:33Speaker 6: So I think there's always opportunities if we stay curious
- 35:37Speaker 6: in these things, and we have a long way to go,
- 35:39Speaker 6: that's for sure.
- 35:41Speaker 2: Got Jenna, I just that kind of gave me chills
- 35:44Speaker 2: because I think that what you did was you know
- 35:51Speaker 2: exactly what we.
- 35:52Speaker 7: All need to be doing.
- 35:54Speaker 2: It's not it's about admitting when we don't know for sure,
- 36:00Speaker 2: but it's about taking the time to dig further, you know,
- 36:05Speaker 2: taking the time, the time to kind of feel the
- 36:08Speaker 2: spaces in between, if you know what I mean, rather
- 36:11Speaker 2: than just kind of going, you know, this is what
- 36:13Speaker 2: I know, and this is what I'm gonna do, and
- 36:14Speaker 2: this is what I know, and this is what I'm
- 36:15Speaker 2: gonna do. Your curiosity and your intelligence and your compassion.
- 36:23Speaker 7: Really drove you to dive.
- 36:25Speaker 2: Deeper maybe than someone else might not have done. Right,
- 36:30Speaker 2: we can I can think of tons of examples of that.
- 36:35Speaker 2: So yes, I mean I think that what you did
- 36:38Speaker 2: was the example of what any health care provider should do.
- 36:44Speaker 10: You know did I'll give you one of mine.
- 36:47Speaker 7: My daughter I had a stroke ten years ago. Is
- 36:54Speaker 7: she uh.
- 36:56Speaker 10: They did testing, she was in the hospital, you know,
- 37:00Speaker 10: et cetera, et cetera.
- 37:01Speaker 2: They ultimately just ad true, you know, they said, this
- 37:04Speaker 2: is your probably birth control pills.
- 37:06Speaker 7: So in twenty nineteen, my.
- 37:09Speaker 2: Daughters had a catastrophic stroke that has left her handicapped.
- 37:15Speaker 2: We were in the ICU for a neuro ICU for
- 37:20Speaker 2: a month, she was in a coma. Her a hemetologist
- 37:26Speaker 2: who is on staff at Bay Care in Saint Petersburg, said,
- 37:32Speaker 2: you know, I just everything's coming up. You know, her
- 37:36Speaker 2: tests all look fine. I'm seeing nothing. I have no idea,
- 37:38Speaker 2: he said, you know I had. I had about you know,
- 37:41Speaker 2: twenty years ago, I was I had a mentor and
- 37:46Speaker 2: we had a patient come in, a young woman who
- 37:49Speaker 2: had a massive heart attack.
- 37:52Speaker 7: And we couldn't figure out what was going on.
- 37:54Speaker 2: And my mentor said, you know, let's test her for
- 37:57Speaker 2: this genetic mutation, and he said, I'm Tess Kayley for
- 38:01Speaker 2: the genetic mutation. Sure enough, it came back that she
- 38:06Speaker 2: has a plasminagen activator inhibitor four G four G mutation
- 38:11Speaker 2: which causes thrombophilia. When she was admitted the hospital for
- 38:15Speaker 2: the second strip, she had clots in her legs amongst
- 38:17Speaker 2: her carotid arteries. Wow, and it was we finally had
- 38:23Speaker 2: a diagnosis, but it took you know that that example
- 38:28Speaker 2: of what I just provided with this physician is exactly
- 38:31Speaker 2: what you did for that patient.
- 38:34Speaker 5: Thank you.
- 38:34Speaker 6: My CFO doesn't like how long it takes you to
- 38:37Speaker 6: work up patients, but that's for another story. Because I
- 38:40Speaker 6: get all, well, it's so curious and go down the
- 38:44Speaker 6: biggest rabbit holes, but I think they sincerely are so important.
- 38:49Speaker 10: The curiosity in the rabbit holes are where the answers lie.
- 38:52Speaker 6: Yes, that is very, very very true. I'm going to
- 38:57Speaker 6: ask a question to Dana now data for the Rarest
- 39:02Speaker 6: Galaxies content, how do you make sure that it's both
- 39:06Speaker 6: engaging and accessible to.
- 39:10Speaker 5: Many diverse audiences.
- 39:14Speaker 8: I'm so sorry, my Internet, I only heard like half of.
- 39:17Speaker 7: That question going in and out.
- 39:21Speaker 10: I'm so sorry, we'll.
- 39:26Speaker 5: Edit it out, so don't worry about it.
- 39:28Speaker 4: That's right, that's the beauty of doing recorded podcasts.
- 39:31Speaker 7: Yeah, we does it.
- 39:32Speaker 5: It doesn't matter.
- 39:33Speaker 6: So we'll all just take like a five second pause
- 39:36Speaker 6: and then I'll re ask the question.
- 39:39Speaker 8: Perfect.
- 39:40Speaker 7: Yeah, it seems to be happy right now. But again,
- 39:44Speaker 7: I'm so sorry.
- 39:46Speaker 6: It's been happening to me all day. So we will
- 39:49Speaker 6: do five second palls. Okay, So this question is for Dana. Dana,
- 39:59Speaker 6: I want to now, how do you ensure that Rarest
- 40:01Speaker 6: galaxies content is both engaging but also accessible to diverse audiences?
- 40:09Speaker 9: Oh? Yes, So making rare disease education engaging isn't just
- 40:17Speaker 9: about simplifying information. It's again meeting people where they are
- 40:22Speaker 9: and recognizing the barriers they face, and designing our content
- 40:27Speaker 9: so that it feels relevant, usable, and empowering. So at Rarest,
- 40:33Speaker 9: I like to follow three core principles to achieve that.
- 40:38Speaker 9: So I always have a cultural and health literacy sensitivity,
- 40:44Speaker 9: so that rare disease education it has to be both
- 40:48Speaker 9: scientifically accurate and inclusive, also using a multi module learning
- 40:56Speaker 9: for different audiences because not everyone learns the same way,
- 41:00Speaker 9: and rare disease education has to be dynamic, to be effective.
- 41:06Speaker 9: So again incorporating the many documentaries in our gains and
- 41:13Speaker 9: interactive learning tools like decision trees and symptom tractors and
- 41:19Speaker 9: tractors and personalized resource hubs, just trying to help patients
- 41:24Speaker 9: and families apply what they've learned to their real life situation,
- 41:29Speaker 9: and then also community driven design. So I believe, and
- 41:35Speaker 9: I think everyone on the RAREST team believes that education
- 41:38Speaker 9: is most powerful when it's co created with the people
- 41:42Speaker 9: that it serves. So the patients and caregivers are not
- 41:47Speaker 9: passive recipients, they are faculty, collaborators, collaborators, and advisors when
- 41:53Speaker 9: we're building our resources, so co developing these educational tools
- 41:59Speaker 9: with the patient and caregivers and advocacy groups to ensure
- 42:03Speaker 9: that the content is real and relatable and truly useful.
- 42:08Speaker 8: That's kind of what we're all about.
- 42:10Speaker 4: Yeah, I love that we need to customize that more
- 42:14Speaker 4: to people. I think back to a story of when
- 42:18Speaker 4: I felt like families felt the impact of the time
- 42:23Speaker 4: I took to educate them. One of the biggest times
- 42:26Speaker 4: was often we'd be on impatient rounds and the families
- 42:30Speaker 4: to be thrown well, we could do these five things
- 42:32Speaker 4: and here's what we're gonna do, and then you could
- 42:34Speaker 4: tell as a caregiver, as a member of that team, Wow,
- 42:38Speaker 4: that was overwhelming to the family. And so for me,
- 42:42Speaker 4: some of the most rewarding times were when I paused
- 42:47Speaker 4: and went back to the family to say, Hey, my
- 42:49Speaker 4: name is Justin, I'm your pharmacist. I know we just
- 42:52Speaker 4: talked about a bunch of things. I'd love to give
- 42:55Speaker 4: you time to process, but could I come back and
- 42:57Speaker 4: maybe we could answer more questions that you have later on.
- 43:00Speaker 4: And just taking that time made such an impact in
- 43:05Speaker 4: that patient and that family's life, and impactful for me
- 43:08Speaker 4: too to see how grateful they were for it. And
- 43:12Speaker 4: you guys are taking that another step. In that moment,
- 43:15Speaker 4: all I had was my knowledge and maybe some handouts
- 43:18Speaker 4: and other things that maybe I found very quickly to
- 43:21Speaker 4: go and educate the patient. But you guys are providing
- 43:23Speaker 4: this immersive approach that balances not only being clear but comprehensive,
- 43:31Speaker 4: not just being concise, but also compassionate, right, And you're
- 43:38Speaker 4: bringing all that together And I'm excited to see how
- 43:41Speaker 4: you guys continue to innovate in this and I think
- 43:44Speaker 4: there's a lot that we can learn as healthcare providers
- 43:46Speaker 4: from you. So I'd love to know as we kind
- 43:49Speaker 4: of transition toward the end of the podcast, what things
- 43:53Speaker 4: excite you most about the work that you're doing right
- 43:56Speaker 4: now at rarest MED, Things that you're working on keeps
- 44:00Speaker 4: you go on every day, and what are.
- 44:01Speaker 1: You excited most about? So Isabelle, I'll start with you.
- 44:04Speaker 7: Yeah, well what excites me most?
- 44:13Speaker 10: You know, we want to be part of and I'm saying.
- 44:16Speaker 7: Part of.
- 44:18Speaker 2: Reshaping how the world learns about and responds to rare diseases,
- 44:24Speaker 2: not just by increasing awareness, but by creating a fundamental
- 44:28Speaker 2: shift in how rare disease education is delivered and accessed
- 44:33Speaker 2: and applied in real world's care.
- 44:36Speaker 7: That feels very It drives me every day. We don't just.
- 44:44Speaker 2: Want people to know more about rare diseases.
- 44:47Speaker 7: We want to the one them to make.
- 44:49Speaker 2: Faster, better and more compassionate decisions. You know, justin back
- 44:53Speaker 2: to what you said about compassion, because I firmly believe
- 44:57Speaker 2: it's all about compassion.
- 45:00Speaker 7: So you know, so the nuts and bolts of that,
- 45:05Speaker 7: you know, sustaining education and research.
- 45:11Speaker 2: Is something that is incredibly important to me and to
- 45:16Speaker 2: many others.
- 45:17Speaker 7: You know, the.
- 45:20Speaker 2: Traditional medical education is not really keeping up with that
- 45:26Speaker 2: with the you know, the knowledge evolution. So we want
- 45:32Speaker 2: to be part of in our small way with education,
- 45:38Speaker 2: the you know, integrating research, helping healthcare providers and patients
- 45:45Speaker 2: using technology. You know, we are very very immersed in
- 45:51Speaker 2: our next iteration of what whereas men will look like,
- 45:54Speaker 2: So that really drives me. One thing that's very near
- 45:59Speaker 2: and dear to me is expanding access and underrepresented communities.
- 46:03Speaker 2: I've done a lot of work there in past lives,
- 46:07Speaker 2: far before rare SMAD.
- 46:09Speaker 10: You know, rare disease care is not equitable. It's not.
- 46:14Speaker 2: Rural communities, lower income families, underserved populations. You know, it's
- 46:20Speaker 2: bad enough having you know, there's a lot of barriers
- 46:22Speaker 2: having a rare disease, and if you're part of an
- 46:26Speaker 2: unrepresented community, you just face greater barriers to diagnosis and treatment. So,
- 46:32Speaker 2: you know, working on ways to translate localized content and
- 46:37Speaker 2: develop things that you know to really reach every patient
- 46:41Speaker 2: everywhere and do some part in.
- 46:44Speaker 7: Creating more equitable care.
- 46:49Speaker 2: As I said, very very invested in advancing intelligence driven learning.
- 46:55Speaker 2: I don't like to call it AI, it's calling it
- 46:58Speaker 2: EI as.
- 47:00Speaker 10: A next generation approach to adaptive, real.
- 47:03Speaker 2: Time education, you know, to do so many things there
- 47:07Speaker 2: that we just can't do now. Just driving systemic change,
- 47:16Speaker 2: policy reforms, partnering you know, like this with pharmacists, and
- 47:22Speaker 2: just the whole rare disease ecosystem of constituents. Those are
- 47:28Speaker 2: some of the things that I'm really excited.
- 47:30Speaker 4: About, Dana. But what about you, How would you answer
- 47:32Speaker 4: that question?
- 47:34Speaker 5: Yeah?
- 47:34Speaker 9: So, just for me specifically working at RARES, what excites
- 47:40Speaker 9: me most is just working with our patients, especially especially on.
- 47:46Speaker 8: The many documentary and games.
- 47:49Speaker 9: I think I've never seen anything like that, And as
- 47:53Speaker 9: someone with a rare disease, being able to connect with
- 47:57Speaker 9: the patients we've worked with, even though we might not
- 48:01Speaker 9: have the same rare disease, it still already feels like
- 48:04Speaker 9: a community. So just further building our community through these
- 48:10Speaker 9: mini docs and our games is just so lovely to
- 48:15Speaker 9: see and kind of just talking with people with other
- 48:19Speaker 9: rare diseases. We just community is everything. And just on
- 48:24Speaker 9: a personal side, when I got my diagnosis, I just
- 48:28Speaker 9: got my diagnosis. I didn't get any kind of help
- 48:33Speaker 9: from my doctors or anyone really, and I honestly found
- 48:38Speaker 9: a tiny community on TikTok of all places.
- 48:42Speaker 5: And that's even.
- 48:43Speaker 9: Where I found out how to give myself my injection,
- 48:47Speaker 9: because I had never been given a medication that was
- 48:51Speaker 9: an injection before. So making these communities and showing an
- 48:58Speaker 9: everyday life is just so important to me as someone
- 49:02Speaker 9: with a rare disease.
- 49:03Speaker 8: And I'm just so excited.
- 49:05Speaker 9: That we're able to do this at Rarest and keep
- 49:09Speaker 9: building and showing.
- 49:10Speaker 8: That you can still live a normal life with a
- 49:14Speaker 8: rare disease and it's it's not all so bad, and
- 49:21Speaker 8: just showing that.
- 49:22Speaker 9: And then again with gaming, creating games that you know,
- 49:26Speaker 9: I think I'm kind of someone I'm a millennial and
- 49:31Speaker 9: I'm not a gamer, but every single other person I
- 49:35Speaker 9: know is a gamer.
- 49:37Speaker 5: So being able.
- 49:38Speaker 8: To create these these games where.
- 49:40Speaker 9: People can interact and like, if they're not so big
- 49:44Speaker 9: on watching a documentary or they don't want to get
- 49:48Speaker 9: education in a more traditional sense, they can play a
- 49:50Speaker 9: game and get and feel like they can understand.
- 49:54Speaker 8: Their own diagnosis better.
- 49:56Speaker 9: I think it's just so exciting and I love it
- 50:00Speaker 9: so much.
- 50:02Speaker 6: Well, thank you guys, It's truly been a pleasure. We
- 50:05Speaker 6: genuinely appreciate your time. Thank you so much for being
- 50:09Speaker 6: on the Pediatric Podcast in review. Last question, I would
- 50:13Speaker 6: love to ask, if someone wants to get ahold.
- 50:15Speaker 5: Of you, where should they go?
- 50:17Speaker 11: Yeah, well, if they go to Rarestmeth www dot raresmet
- 50:26Speaker 11: dot com, you can find out a lot about us
- 50:34Speaker 11: and there are also contact numbers for us and you
- 50:39Speaker 11: can even see our you know again, we've only been
- 50:43Speaker 11: here a year, so we we do have our hereditary
- 50:48Speaker 11: in geo a Deema program.
- 50:50Speaker 10: That is all the different pieces are linked on the site.
- 50:53Speaker 7: We will be.
- 50:55Speaker 10: Launching h a E the initiatives for h a E
- 50:59Speaker 10: very soon, and we just keep.
- 51:01Speaker 2: Going and we love to hear from anybody and everybody,
- 51:05Speaker 2: so reach out to us.
- 51:06Speaker 7: We will respond immediately.
- 51:09Speaker 9: And also on social media just at raris, r A,
- 51:13Speaker 9: r U, s Med and b D. We are on Facebook, Instagram, TikTok, LinkedIn,
- 51:20Speaker 9: We're literally everywhere.
- 51:21Speaker 7: You can find us on any platform.
- 51:23Speaker 8: We're there.
- 51:26Speaker 5: I love that. Well, thank you, ladies.
- 51:27Speaker 6: It's always a pleasure and we genuinely appreciate your time.
- 51:32Speaker 7: And we do as well. So wonderful to meet you
- 51:34Speaker 7: all and talk.
- 51:36Speaker 5: Thank you, fair bye bye.
- 51:38Speaker 1: That's all for today's episode.
- 51:40Speaker 3: Thanks for listening, and remember to subscribe on Apple podcast
- 51:43Speaker 3: and leave us a review